日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.

硬膜趋化作用是肺纤维化和转移性胰腺癌的驱动因素和潜在治疗靶点

Al-Hilal Taslim A, Chrysovergi Maria-Anna, Grasberger Paula E, Liu Fei, Auernheimer Vera, Zhou Yan, Xiao Zebin, Leon-Duque Mark Anthony, Santos Alba, Islam Tamanna, Ligorio Matteo, Sicard Delphine, Probst Clemens K, Vrbanac Vladimir, Reddi Tejaswini S, Vincent Ludovic, Happe Cassandra, Chaum Edward, Yates Charles R, Daneshvar Kaveh, Mullen Allan C, Ting David, White Eric S, Kalluri Raghu, Woo Christina M, Puré Ellen, Goldmann Wolfgang H, Alonso Jose Luis, Tager Andrew M, Engler Adam J, Tschumperlin Daniel J, Lagares David

Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B

桑格利芬A通过靶向胶原蛋白伴侣蛋白环孢亲和素B来减轻多器官纤维化。

Flaxman, Hope A; Chrysovergi, Maria-Anna; Han, Hongwei; Kabir, Farah; Lister, Rachael T; Chang, Chia-Fu; Yvon, Robert; Black, Katharine E; Weigert, Andreas; Savai, Rajkumar; Egea-Zorrilla, Alejandro; Pardo-Saganta, Ana; Lagares, David; Woo, Christina M